First Confirmed Case of Tegoprazan‐Induced Anaphylaxis Demonstrated by Drug Provocation Testing
Abstract
Tegoprazan, a potassium‐competitive acid blocker, is commonly prescribed for the treatment of acid‐related gastrointestinal diseases. Aside from a single reported case of tegoprazan‐induced urticaria, no serious hypersensitivity reactions have been documented. Herein, we present a case of tegoprazan‐induced anaphylaxis that evolved from an earlier and less severe reaction. The first episode manifested as manageable urticarial eruptions and resolved after discontinuation of the medication, whereas re‐exposure provoked immediate anaphylaxis, with the initial cutaneous reaction escalating to systemic involvement with hypotension. A 42‐year‐old woman with nonerosive reflux disease presented to the emergency room (ER) with the sudden onset of a generalized rash after taking medications, including tegoprazan, for 8 days. After medical treatment and drug discontinuation, the patient’s symptoms improved without recurrence. However, 9 days later, immediately after readministration of the same drugs, she experienced severe shortness of breath, dizziness, facial swelling, generalized rash, itching, temporary loss of consciousness, and hypotension. The patient was transferred to the ER, where anaphylaxis was diagnosed. Following the administration of a single dose of intramuscular epinephrine, her systemic symptoms improved. Drug provocation tests (DPTs), together with a high Naranjo score, strongly supported tegoprazan as the culprit drug at the patient level. To our knowledge, this is…
Read the paper
Related studies
- Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants
- Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.